CS logo
small CS logo
King Faisal Specialist Hospital & Research Center

Riyadh, Saudi Arabia
مستشفى في الرياض

About King Faisal Specialist Hospital & Research Center


مستشفى الملك فيصل التخصصي ومركز الأبحاث هو مستشفى تخصصي يقع في مدينة الرياض في المملكة العربية السعودية. يقدم المستشفى ومركز الأبحاث رعاية صحية أولية للمرضى المنومين والمُراجعين، ويشارك في العديد من الدراسات السريرية والبحثية.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
King Faisal Specialist Hospital & Research Center
49
Children's Oncology Group
10
Pfizer
5
NRG Oncology
4
National Cancer Institute (NCI)
4
Hoffmann-La Roche
3
Medtronic Cardiac Rhythm and Heart Failure
3
Actelion
2
Albireo
2
Duke University
2
Eli Lilly and Company
2
Total Rows: 41

Clinical Trials at King Faisal Specialist Hospital & Research Center


During the past decade, King Faisal Specialist Hospital & Research Center conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 15 clinical trials were completed, i.e. on average, 24.2% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 10 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years995511118855141488221100221111115522Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma
1993-08-01
Completed
214
Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis
2005-12-27
2008-03-29
Completed
752
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
2007-01-24
2018-09-04
Completed
64
Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
2007-03-01
Completed
230
A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248
2007-02-01
2012-06-01
Completed
350
Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor
2001-03-01
2015-06-01
Completed
350
Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil
2002-07-01
2012-06-01
Unknown status
350
Sodium Bicarbonate in Preventing Contrast Induced Nephropathy
2007-06-01
2010-05-01
Completed
220

Rows per page:

1–100 of 121

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "King Faisal Specialist Hospital & Research Center" #1 sponsor was "King Faisal Specialist Hospital & Research Center" with 49 trials, followed by "Children's Oncology Group" with 10 trials sponsored, "Pfizer" with 5 trials sponsored, "NRG Oncology" with 4 trials sponsored and "National Cancer Institute (NCI)" with 4 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 41 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "King Faisal Specialist Hospital & Research Center" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Children's Hospital of Philadelphia" with 2 trials as a collaborator and "King Faisal Specialist Hospital & Research Center" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 36 trials.
Created with Highcharts 11.1.0Top Leading SponsorsKing Faisal SpecialistHospital & ResearchCenter: 49King Faisal SpecialistHospital & ResearchCenter: 49Children's Oncology Group: 10Children's Oncology Group: 10Pfizer: 5Pfizer: 5NRG Oncology: 4NRG Oncology: 4National Cancer Institute (NCI): 4National Cancer Institute (NCI): 4Hoffmann-La Roche: 3Hoffmann-La Roche: 3Medtronic CardiacRhythm and HeartFailure: 3Medtronic CardiacRhythm and HeartFailure: 3Actelion: 2Actelion: 2Albireo: 2Albireo: 2Duke University: 2Duke University: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 21National CancerInstitute (NCI): 21Canadian Institutes ofHealth Research (CIHR):3Canadian Institutes ofHealth Research (CIHR):3NRG Oncology: 3NRG Oncology: 3Children's Hospital ofPhiladelphia: 2Children's Hospital ofPhiladelphia: 2King Faisal SpecialistHospital & ResearchCenter: 2King Faisal SpecialistHospital & ResearchCenter: 2Novartis: 2Novartis: 2Radiation TherapyOncology Group: 2Radiation TherapyOncology Group: 2AstraZeneca: 1AstraZeneca: 1Buraidah Central Hospital: 1Buraidah Central Hospital: 1Chugai Pharmaceutical: 1Chugai Pharmaceutical: 1

Clinical Trials Conditions at King Faisal Specialist Hospital & Research Center


According to Clinical.Site data, the most researched conditions in "King Faisal Specialist Hospital & Research Center" are "Breast Cancer" (6 trials), "COVID-19" (4 trials), "Critical Illness" (4 trials), "Vitamin D Deficiency" (4 trials) and "Hemophilia A" (3 trials). Many other conditions were trialed in "King Faisal Specialist Hospital & Research Center" in a lesser frequency.

Clinical Trials Intervention Types at King Faisal Specialist Hospital & Research Center


Most popular intervention types in "King Faisal Specialist Hospital & Research Center" are "Drug" (70 trials), "Other" (37 trials), "Procedure" (18 trials), "Radiation" (12 trials) and "Biological" (7 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Placebo" (9 trials), "Etoposide" (7 trials), "Cisplatin" (5 trials) and "Cyclophosphamide" (5 trials). Other intervention names were less common.

Clinical Trials Genders at King Faisal Specialist Hospital & Research Center


The vast majority of trials in "King Faisal Specialist Hospital & Research Center" are 110 trials for "All" genders, 7 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at King Faisal Specialist Hospital & Research Center


Currently, there are NaN active trials in "King Faisal Specialist Hospital & Research Center". undefined are not yet recruiting, 30 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 50 completed trials in King Faisal Specialist Hospital & Research Center, 1 suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in King Faisal Specialist Hospital & Research Center, 3 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 25 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 42Phase 3: 42Not Applicable: 25Not Applicable: 25Phase 2: 19Phase 2: 19Phase 4: 7Phase 4: 7Phase 1: 3Phase 1: 3Early Phase 1: 1Early Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 50Completed: 50Recruiting: 30Recruiting: 30Active, not recruiting: 17Active, not recruiting: 17Unknown status: 16Unknown status: 16Terminated: 3Terminated: 3Withdrawn: 2Withdrawn: 2Available: 1Available: 1Enrolling by invitation: 1Enrolling by invitation: 1Suspended: 1Suspended: 1

Departments of King Faisal Specialist Hospital & Research Center


King Faisal Specialist Hospital & Research Center has several departments that took part in Clinical trials: "King Faisal Specialist Hospital & Research Centre; Oncology" - 6 trials
Departments List
Total Rows: 1